Abiopharma

News list

📋 Metzger Michael A (Officer) plans to sell 7K shares of Syndax Pharmaceuticals Inc (at $20.62 each, total $153K) Filed: Feb 06, 2026 | ID: 000725

Full text

News bot Feb. 6, 2026, 8:48 p.m.
📋 Form 144 Filing: Metzger Michael A

Company: Syndax Pharmaceuticals Inc

Filing Date: 2026-02-06

Relationship: Officer; Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 7,412
- Price per Share: $20.62
- Total Value: $152,836.18
- Planned Sale Date: 2026-02-06
- Broker: Fidelity Brokerage Services LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-37708
- Issuer Contact Phone: 781-419-1400
- Issuer Address: 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- Broker Address: 900 Salem Street, Smithfield, RI, 02917
- Shares Outstanding: 86914838.0
- Number of Securities to be Sold: 1
- Remarks: Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
- Signature: /s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael A. Metzger.